Appendix D
Workshop Agenda
NATIONAL ACADEMY OF SCIENCES INSTITUTE OF MEDICINE
FORUM ON EMERGING INFECTIONS
"Antimicrobial Resistance, Surveillance, and Response"
2101 Constitution Avenue, N.W., Washington, D.C.
July 30-31, 1997
|
WEDNESDAY, July 30th |
|
|
9:00 |
WELCOME AND INTRODUCTION Joshua Lederberg, Forum Chairman |
|
9:15 |
WHY ARE WE HERE? A FIRST LOOK AT THE COSTS OF ANTIMICROBIAL RESISTANCE Robert Rubin, The Lewin Group |
|
9:30 |
TRACKING THE PROBLEM: APPROACHES TO SURVEILLANCE AND WHAT IS NEEDED An Overview David Bell, CDC |
|
|
The Global Perspective David Heymann, WHO |
|
|
A National Model Donald Low, Canada |
|
|
A Network for Research Karl Kristinsson, CEM/NET |
|
|
A U.S. State Perspective Michael Osterholm, Minnesota Department of Health |
|
10 45 |
INTEGRATING PRIVATE- AND PUBLIC-SECTOR SURVEILLANCE: WHAT IS HAPPENING AND WHAT IS NEEDED Rosamund Williams, WHO Renu Gupta, Bristol-Myers Squibb Laurence McCarthy, MRL Pharmaceutical Services |
|
11:30 |
SURVEILLANCE AND THE LABORATORY: WHAT ARE THE ISSUES? Fred Tenover, CDC |
|
11:45 |
HOW CAN THE SCIENCE HELP? Implications of Mapping the Genome Craig Venter, Institute for Genomic Research |
|
|
Molecular Detection of Genes Associated with Antimicrobial Resistance David Relman, Stanford University |
|
12:30 |
LUNCH |
|
1:30 |
HOW CAN THE SCIENCE HELP? (continued) High-Density Oligonucleotide Arrays Tom Gingeras, Affymetrix |
|
|
Applications of Genomics/Bioinformatics to Development of Anti-Infectives George Miller, Schering-Plough Research Institute |
|
|
A Role for New Therapeutic Approaches in Combating Antimicrobial Resistance Mich Hein, EPIcyte |
|
|
Applications of Field Surveillance (U.S. and International) Thomas Quinn, Johns Hopkins University |
|
2:30 |
SOURCES OF RESISTANCE AND NOTIONS OF RESPONSE Stuart Levy, Tufts University |
|
2:45 |
ISSUES OF JUDICIOUS ANTIBIOTIC USE Mitchell Cohen, CDC |
|
3:00 |
ISSUES IN AND STRATEGIES FOR CLINICAL USE OF ANTIMICROBIALS Michael Marcy, Kaiser Permanente |
|
3:15 |
BREAK |
|
3:30 |
RESISTANCE AND FOOD PRODUCTION: WHAT ISSUES, WHAT NEEDS? |
|
|
Concerns and Perspectives from Producers Paul Sundberg, National Pork Producers Council |
|
|
Salmonella DT104 on the Farm John Gay, Washington State University |
|
|
Concerns and Perspectives from the U.S. Department of Agriculture Bob Buchanan, USDA/ARS/ERRC Kaye Wachsmuth, USDA/FSI |
|
|
Concerns and Perspectives from the U.S. Environmental Protection Agency Mark Wilhite, EPA |
|
4:45 |
DISCUSSION |
|
5:30 |
ADJOURN |
|
THURSDAY, JULY 31 |
|
|
8:30 |
OTHER CONCERNS AND MECHANISMS OF RESPONSE Legal Issues Arising from Development of Antimicrobial Resistance David Fidler, University of Indiana |
|
|
Expired Patents and the Potential of Existing Compounds* Discussants: Gerald Mossinghoff, George Washington School of Law Vincent Ahonkhai, SmithKline Beecham |
|
|
Restricted Distribution and the Market** General Discussion with FDA participants as resources |
|
|
Orphan Drug Act Update: Looking Through the Prism of Staphylococcus aureus in Japan* Discussants: Fred Tenover, CDC Mark Goldberger, FDA |
|
10:00 |
GENERAL DISCUSSION: REVISITING YESTERDAY'S TOPICS AND EXTRACTING TAKEAWAY LESSONS, ISSUES, AND NEXT STEPS |
|
11:00 |
ADJOURNMENT |
